Syneron, the makers of the VelaShape body contouring system and eMatrix aesthetic medical devices, unveiled a new fractional laser treatment at the American Academy of Dermatology this March.
The e2 device is a combination of fractional epidermal and dermal sublative laser treatment, and promises to help improve the texture and tone of the skin while reducing wrinkles.
The e2 device is designed to treat patients with mild to moderate scarring, pigmentation, skin laxity and wrinkles, and is most suitable for patients who do not want to undergo more aggressive treatments such as the Fraxel laser resurfacing procedure or the Erbium laser.
Syneron’s e2 device is performed using the eMatrix system that uses two different treatment tips for epidermal and dermal rejuvenation. The system is designed with the Sublative RF Dermal Rejuvenation tip and the Sublative RF for Epidermal Rejuvenation tip. The Sublative RF Dermal Rejuvenation tip can be used as a standalone treatment, or in conjunction with the epidermal tip to improve the skin tone and get rid of traces of scars. Since it is a non-invasive procedure, patients enjoy very little downtime and do not experience a significant amount of discomfort.
According to Dr. Lori Brightman, a board-certified dermatologist at the Skin Laser & Surgery Specialists of New York, “Our e2 treatment clinical trials yield impressive results for multiple indications in the dermal and epidermal layers of the skin including scar revision and textural irregularities…I can address a complete range of skin rejuvenation concerns with reliable, consistent results from one system.” (Source: Syneron Asia Blog)
The sublative rejuvenation treatment program is a good match for darker skin types because there is little risk of excessive scarring or pigmentation with the procedure. Most people complete the healing process within a week to two weeks after the treatment, and the procedure can be administered by a board-certified dermatologist or licensed medical aesthetician.